Keyphrases
Sentinel Lymph Node Biopsy
66%
Indocyanine Green
66%
Early Breast Cancer
46%
Radioisotopes
45%
Breast Cancer
40%
Indocyanine Green Fluorescence
40%
Breast Cancer Sentinel Lymph Node
33%
Bilateral Breast
33%
Effective Alternative
33%
Leukocytoclastic Vasculitis
33%
First Case Report
33%
Breast Surgeon
33%
Body Mass Index
33%
Surgical Management
33%
Safer Alternatives
33%
COVID-19 Pandemic Impact
33%
Prospective Randomized Trial
33%
Blue Dye
25%
Virtual Meetings
16%
COVID-19 Pandemic
16%
Being Adopted
16%
Surgical Practice
16%
Node-positive
13%
Nodal Count
13%
Detection Rate
13%
Positivity Rate
11%
Bilateral Mastectomy
11%
Life-limiting Conditions
11%
Older Women
11%
Multidisciplinary Approach
11%
Multiple Sclerosis
11%
Debridement
11%
Rapid Assessment
11%
Anterior Abdominal Wall
11%
Immune Complex
11%
Glatiramer Acetate
11%
Rapidly Evolving
11%
Small Vessels
11%
Vessel Wall
11%
Standard of Care
10%
Surgical Priority
8%
Surgical Oncologist
8%
COVID-19 Emergency
8%
Surgical Activity
8%
COVID-19 Spread
8%
Primary Systemic Therapy
8%
Hospital Resources
8%
Breast Cancer Surgery
8%
Affected Area
8%
Aggressive Disease
8%
Medicine and Dentistry
Breast Cancer
100%
Indocyanine Green
66%
Sentinel Lymph Node Biopsy
66%
Radioisotope
44%
Body Mass Index
33%
Surgeon
33%
COVID-19
33%
Surgery
33%
Hypersensitivity Angiitis
33%
Radioactive Tracer
33%
Systemic Therapy
13%
Disease
13%
Glatiramer
11%
Rapid Assessment
11%
Mastectomy
11%
Antigen Antibody Complex
11%
Abdominal Wall
11%
Multiple Sclerosis
11%
Debridement
11%
Sentinel Node
6%
Progressive Disease
6%
Histopathology
6%
Operating Room
6%
Personal Data
6%
Breast Cancer Surgery
6%
Consultation
6%
Neoadjuvant Therapy
6%
Meta-Analysis
6%
Axilla
6%
Nodal Metastasis
6%
Oncologist
6%
Elective Surgery
6%
